PCRX
Pacira Biosciences Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 5/10
- Momentum↓ 3/10
PCRX Growth
- Revenue Y/Y↓ 3.14%
- EPS Y/Y↑ 123.35%
- FCF Y/Y↓ -35.82%
PCRX Profitability
- Gross margin ↑ 79.20%
- EPS margin↓ 3.00%
- ROIC↓ 5.30%
PCRX Risk
- Debt / Equity↓ 0.6
- Debt / FCF↓ 2.2
- Interest coverage↓ 3.3
Pacira Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.